What does NCE stand for?

New Chemical Entity (pharmaceutical research)

This definition appears very rarely and is found in the following Acronym Finder categories:

Science, medicine, engineering, etc.

Other Resources:

<< Previous	Abbreviation Database Surfer		Next >>
Net Control Element Net-Centric Enterprise Network Capacity Expansion (Cisco) Network Configuration Editor Network Connection Endpoint Network Consulting Engineer (various companies) Networks of Centres of Excellence Neutral Current Eliminator (Mirus International Inc.) New Catholic Encyclopedia New Century Energies		New Civil Engineer (UK Journal) Newark College of Engineering (New Jersey Institute of Technology) NGA (National Geospatial Intelligence Agency) Campus East (Bethesda, MD) Nice, France - Cote D'azur (Airport Code) Nigeria Certificate in Education No-Cost Extension Nomadic Computing Environment Non-Commercial Educational Non-Conventional Energy (India) Non-Credit Union Entity (US National Credit Union Association)

Samples in periodicals archive:

It`s research activities encompass process engineering for APIs, new chemical entity research and novel drug delivery systems.

India: GPL approves conversion of USD 7.5 millionn ZCB into equities

Tucked away at the end of the Food and Drug Administration Amendments Act of 2007 (FDAAA) is a provision that modifies FDA's long-standing refusal to award five-year new chemical entity (NCE) exclusivity to enantiomers of previously-approved racemic mixtures.

Enantiomer Exclusivity Revisited - The Food and Drug Administration ...

XP13512 is a new chemical entity that is a Transported Prodrug of gabapentin, an agent indicated for the treatment of seizure and neuropathic pain.

Astellas Pharma, XenoPort Conclude Licensing Agreement for XP13512 ...

To be eligible for Data Exclusivity, a product should meet the criteria of New Chemical Entity as per patent law but the registration data and innovation are two separate intellectual properties.

Data Exclusivity & Patents Unrelated

RX-3117 is a small molecule, new chemical entity (NCE), nucleoside compound that has an anti-metabolite mechanism of action, and has therapeutic potential in a broad range of cancers including colon, lung and pancreatic cancer.

Rexahn Pharmaceuticals and Teva Pharmaceutical Industries Agree to ...

Rexahn Pharmaceuticals Signs Development and Commercialization ...

Drugmakers have reported few problems with the approvals process, which, at around 12 months for a new chemical entity (NCE), is swift by regional standards.

Research and Markets: A Detailed Analysis of the Moroccan ...

CTP-347 is a new chemical entity developed from Concert's deuterium chemistry platform by replacing key hydrogen atoms of paroxetine with deuterium.

Concert Pharmaceuticals Initiates CTP-347 Phase I Clinical Trial